Adolescent Survivors of Cancer or Similar Illnesses

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00579631
Recruitment Status : Active, not recruiting
First Posted : December 24, 2007
Last Update Posted : January 17, 2018
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

Brief Summary:
The purpose of this study is to examine the health behaviors of young adults who have been treated for cancer, leukemia, or similar illnesses. We will also ask you some questions about your family members' and friends' health behaviors. We plan to use the findings from this study to design new programs to help teenage cancer survivors resist doing things that might harm their health.

Condition or disease Intervention/treatment
Adolescent Cancer Survivors Pediatric Cancer Survivors Behavioral: Questionnaire or Interview

Detailed Description:
This study proposes to explore cancer-risk behaviors and future behavioral intentions among adolescent cancer survivors (i.e., 14-19 years old) and compare them to their "healthy" peers using population-based normative data. Additionally, it seeks to determine the significant theory-driven covariates related to adolescent survivors' health behaviors, which will aid in the design of future behavioral interventions.

Study Type : Observational
Estimated Enrollment : 148 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Health Behaviors in Adolescent Survivors of Cancer or Similar Illnesses
Study Start Date : June 2004
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : June 2019

Resource links provided by the National Library of Medicine

Group/Cohort Intervention/treatment
Questionnaire or Interview
Behavioral: Questionnaire or Interview
Complete a self-report survey once over the telephone or by mail. The questions are about your health beliefs and behaviors, your current health, and your mood. It should not take longer than 45 minutes to complete. About 15 of these people will participate in an additional, short audiotaped interview about sun protection.

Primary Outcome Measures :
  1. To describe the patterns of cancer-risk behaviors for adolescent cancer survivors as compared to population-based normative data of "healthy" adolescents, and to describe relevant theory-driven covariates for adolescent cancer survivors. [ Time Frame: conclusion of study ]

Secondary Outcome Measures :
  1. To examine the role and relative utility of sociodemographics, medical characteristics, theory-driven variables in explaining adolescent cancer survivors' health behaviors. [ Time Frame: conclusion of study ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   14 Years to 19 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Memorial Sloan-Kettering Cancer Center's Department of Pediatrics

Inclusion Criteria:

  • Current age at enrollment between 14 and 19;
  • A diagnosis of cancer between the ages of 8 and 14;
  • At least 12 months post-treatment and no evidence of disease (NED) at the time of assessment;
  • Can be reached by mail or telephone;
  • Fluent in English;
  • Parent or legal guardian able to provide informed consent;
  • Able to provide informed assent.

Exclusion Criteria:

  • Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.
  • Currently receiving therapy for cancer treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00579631

United States, New York
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
Principal Investigator: Jennifer Ford, PhD Memorial Sloan Kettering Cancer Center

Additional Information:
Responsible Party: Memorial Sloan Kettering Cancer Center Identifier: NCT00579631     History of Changes
Other Study ID Numbers: 04-074
First Posted: December 24, 2007    Key Record Dates
Last Update Posted: January 17, 2018
Last Verified: January 2018

Keywords provided by Memorial Sloan Kettering Cancer Center: